Functional and quality-of-life outcomes after reirradiation for head and neck cancer

Allen M. Chen, Esther Vazquez, Anthony L. Michaud, D Gregory Farwell, James A. Purdy

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives/Hypothesis To examine functional and quality-of-life outcomes for patients treated by reirradiation to the head and neck for recurrent or new primary cancers. Study Design Retrospective review. Methods The University of Washington Quality of Life Instrument (UW-QOL) scores were reviewed with swallow evaluations for 17 patients with biopsy-proven recurrent or new primary squamous cell carcinoma of the head and neck treated with reirradiation who were clinically without evidence of disease at a minimum follow-up of 1 year. All patients had received their initial radiation therapy to a median dose of 66 Gy (range, 60-72 Gy). The median interval between radiation courses was 30 months (range, 6-132 months). The median reirradiation dose was 60 Gy (range, 54-70 Gy). Results At 1 year after reirradiation, the mean UW-QOL composite score was 67.0 (range, 22.1-83.5), which did not differ significantly from baseline (P=.57). The proportion of patients who rated their global quality of life as "very good" or "outstanding" at 1 year after reirradiation was 35%. The percentage of patients who reported their global quality of life as "good/fair" and "poor/very poor" were 59% and 6%, respectively. Conclusions The majority of survivors in this highly selected series were devoid of new impairment after reirradiation and were satisfied with their functional status. Although nearly all patients had side effects from their prior radiation course prior to reirradiation, no patient reported a decline in global quality of life from before reirradiation to 1 year post-treatment.

Original languageEnglish (US)
Pages (from-to)1807-1812
Number of pages6
JournalLaryngoscope
Volume124
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Head and Neck Neoplasms
Quality of Life
Radiation
Re-Irradiation
Deglutition
Survivors
Neck
Radiotherapy
Retrospective Studies
Head
Biopsy
Neoplasms

Keywords

  • Function
  • head and neck cancer
  • quality of life
  • recurrent
  • reirradiation

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Functional and quality-of-life outcomes after reirradiation for head and neck cancer. / Chen, Allen M.; Vazquez, Esther; Michaud, Anthony L.; Farwell, D Gregory; Purdy, James A.

In: Laryngoscope, Vol. 124, No. 8, 2014, p. 1807-1812.

Research output: Contribution to journalArticle

Chen, Allen M. ; Vazquez, Esther ; Michaud, Anthony L. ; Farwell, D Gregory ; Purdy, James A. / Functional and quality-of-life outcomes after reirradiation for head and neck cancer. In: Laryngoscope. 2014 ; Vol. 124, No. 8. pp. 1807-1812.
@article{38c5618723064d9c982ac6d853dce187,
title = "Functional and quality-of-life outcomes after reirradiation for head and neck cancer",
abstract = "Objectives/Hypothesis To examine functional and quality-of-life outcomes for patients treated by reirradiation to the head and neck for recurrent or new primary cancers. Study Design Retrospective review. Methods The University of Washington Quality of Life Instrument (UW-QOL) scores were reviewed with swallow evaluations for 17 patients with biopsy-proven recurrent or new primary squamous cell carcinoma of the head and neck treated with reirradiation who were clinically without evidence of disease at a minimum follow-up of 1 year. All patients had received their initial radiation therapy to a median dose of 66 Gy (range, 60-72 Gy). The median interval between radiation courses was 30 months (range, 6-132 months). The median reirradiation dose was 60 Gy (range, 54-70 Gy). Results At 1 year after reirradiation, the mean UW-QOL composite score was 67.0 (range, 22.1-83.5), which did not differ significantly from baseline (P=.57). The proportion of patients who rated their global quality of life as {"}very good{"} or {"}outstanding{"} at 1 year after reirradiation was 35{\%}. The percentage of patients who reported their global quality of life as {"}good/fair{"} and {"}poor/very poor{"} were 59{\%} and 6{\%}, respectively. Conclusions The majority of survivors in this highly selected series were devoid of new impairment after reirradiation and were satisfied with their functional status. Although nearly all patients had side effects from their prior radiation course prior to reirradiation, no patient reported a decline in global quality of life from before reirradiation to 1 year post-treatment.",
keywords = "Function, head and neck cancer, quality of life, recurrent, reirradiation",
author = "Chen, {Allen M.} and Esther Vazquez and Michaud, {Anthony L.} and Farwell, {D Gregory} and Purdy, {James A.}",
year = "2014",
doi = "10.1002/lary.24505",
language = "English (US)",
volume = "124",
pages = "1807--1812",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Functional and quality-of-life outcomes after reirradiation for head and neck cancer

AU - Chen, Allen M.

AU - Vazquez, Esther

AU - Michaud, Anthony L.

AU - Farwell, D Gregory

AU - Purdy, James A.

PY - 2014

Y1 - 2014

N2 - Objectives/Hypothesis To examine functional and quality-of-life outcomes for patients treated by reirradiation to the head and neck for recurrent or new primary cancers. Study Design Retrospective review. Methods The University of Washington Quality of Life Instrument (UW-QOL) scores were reviewed with swallow evaluations for 17 patients with biopsy-proven recurrent or new primary squamous cell carcinoma of the head and neck treated with reirradiation who were clinically without evidence of disease at a minimum follow-up of 1 year. All patients had received their initial radiation therapy to a median dose of 66 Gy (range, 60-72 Gy). The median interval between radiation courses was 30 months (range, 6-132 months). The median reirradiation dose was 60 Gy (range, 54-70 Gy). Results At 1 year after reirradiation, the mean UW-QOL composite score was 67.0 (range, 22.1-83.5), which did not differ significantly from baseline (P=.57). The proportion of patients who rated their global quality of life as "very good" or "outstanding" at 1 year after reirradiation was 35%. The percentage of patients who reported their global quality of life as "good/fair" and "poor/very poor" were 59% and 6%, respectively. Conclusions The majority of survivors in this highly selected series were devoid of new impairment after reirradiation and were satisfied with their functional status. Although nearly all patients had side effects from their prior radiation course prior to reirradiation, no patient reported a decline in global quality of life from before reirradiation to 1 year post-treatment.

AB - Objectives/Hypothesis To examine functional and quality-of-life outcomes for patients treated by reirradiation to the head and neck for recurrent or new primary cancers. Study Design Retrospective review. Methods The University of Washington Quality of Life Instrument (UW-QOL) scores were reviewed with swallow evaluations for 17 patients with biopsy-proven recurrent or new primary squamous cell carcinoma of the head and neck treated with reirradiation who were clinically without evidence of disease at a minimum follow-up of 1 year. All patients had received their initial radiation therapy to a median dose of 66 Gy (range, 60-72 Gy). The median interval between radiation courses was 30 months (range, 6-132 months). The median reirradiation dose was 60 Gy (range, 54-70 Gy). Results At 1 year after reirradiation, the mean UW-QOL composite score was 67.0 (range, 22.1-83.5), which did not differ significantly from baseline (P=.57). The proportion of patients who rated their global quality of life as "very good" or "outstanding" at 1 year after reirradiation was 35%. The percentage of patients who reported their global quality of life as "good/fair" and "poor/very poor" were 59% and 6%, respectively. Conclusions The majority of survivors in this highly selected series were devoid of new impairment after reirradiation and were satisfied with their functional status. Although nearly all patients had side effects from their prior radiation course prior to reirradiation, no patient reported a decline in global quality of life from before reirradiation to 1 year post-treatment.

KW - Function

KW - head and neck cancer

KW - quality of life

KW - recurrent

KW - reirradiation

UR - http://www.scopus.com/inward/record.url?scp=84904730225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904730225&partnerID=8YFLogxK

U2 - 10.1002/lary.24505

DO - 10.1002/lary.24505

M3 - Article

VL - 124

SP - 1807

EP - 1812

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 8

ER -